John Maraganore is a director of ProKidney Corp - Ordinary Shares.
Person profile
Roles
ProKidney Corp - Ordinary Shares
Director
Kymera Therapeutics
Director
Beam Therapeutics
Director
Agios Pharmaceuticals
Director
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
PROKIDNEY CORP.
3 Jul 23
4
Kymera Therapeutics, Inc.
20 Jun 23
4
Beam Therapeutics Inc.
8 Jun 23
5
AGIOS PHARMACEUTICALS, INC.
3 Feb 23
4
Beam Therapeutics Inc.
2 Sep 22
4
PROKIDNEY CORP.
13 Jul 22
3
PROKIDNEY CORP.
13 Jul 22
4
AGIOS PHARMACEUTICALS, INC.
23 Jun 22
4
AGIOS PHARMACEUTICALS, INC.
24 May 22
4
Kymera Therapeutics, Inc.
19 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jun 23 | PROK ProKidney Corp - Ordinary Shares | Director stock option Class A Ordinary Shares | Grant | Acquire A | No | No | 10.56 | 48,128 | 508.23 k | 48,128 |
15 Jun 23 | KYMR Kymera Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 27.67 | 12,000 | 332.04 k | 12,000 |
6 Jun 23 | BEAM Beam Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 34.33 | 16,532 | 567.54 k | 16,532 |
20 Sep 22 | AGIO Agios Pharmaceuticals | Common stock | Gift | Dispose G | No | No | 0 | 1,500 | 0.00 | 28,528 |